Boost for Medical, Biotechnological, and Pharmaceutical Research. Technology developer and manufacturer Demcon acquired a majority stake in Orgonex at the end of last year. The spin-off from Utrecht University / the Innovation Center for Advanced Therapies (ICAT) has developed a bioreactor for cultivating organoids. Organoids are miniature organs used for medical, biotechnological, and pharmaceutical research. Orgonex's bioreactor yields five times higher than traditional manual cultivation methods and is more compact and straightforward than other automated cultivation solutions. This system offers an accessible solution for efficiently cultivating sufficient organoids and can be easily integrated into existing laboratory infrastructures at academic research groups and pharmaceutical companies. Together with Demcon, Orgonex is now developing the bioreactor into a professional system that will be launched later this year.